Molecular and cellular defects in nephrogenic diabetes insipidus
- PMID: 11793119
- DOI: 10.1007/s004670100051
Molecular and cellular defects in nephrogenic diabetes insipidus
Abstract
The identification of the different molecular causes of congenital nephrogenic diabetes insipidus (NDI), a disorder characterized by renal insensitivity to the antidiuretic effect of arginine vasopressin, has been of indispensable importance for understanding the cellular processes involved in diuresis and antidiuresis. In most cases, NDI is X-linked and caused by mutations in the vasopressin type-2 receptor (V2R) gene. Mutations in the aquaporin-2 (AQP2) water channel gene are responsible for the autosomal recessive and rare dominant forms of NDI. By in vitro expression, it has been shown that the majority of V2R mutants and all AQP2 mutants found in recessive NDI are misfolded and retained within the endoplasmic reticulum (ER). Functional analysis of one of the mutations identified in dominant NDI showed that this mutant is properly folded and transported out of the ER, but is retained in the Golgi region. In addition, this mutant, in contrast to mutants found in recessive NDI, is able to heterotetramerize with wild-type AQP2. The resulting complex is hindered in its transport to the membrane, a finding that explains the dominant-negative effect of this mutation. Several new methodologies focused on the molecular defects causing NDI are presently being investigated in vitro and might eventually develop into useful therapeutic strategies.
Similar articles
-
A novel mechanism in recessive nephrogenic diabetes insipidus: wild-type aquaporin-2 rescues the apical membrane expression of intracellularly retained AQP2-P262L.Hum Mol Genet. 2004 Dec 15;13(24):3045-56. doi: 10.1093/hmg/ddh339. Epub 2004 Oct 27. Hum Mol Genet. 2004. PMID: 15509592
-
An impaired routing of wild-type aquaporin-2 after tetramerization with an aquaporin-2 mutant explains dominant nephrogenic diabetes insipidus.EMBO J. 1999 May 4;18(9):2394-400. doi: 10.1093/emboj/18.9.2394. EMBO J. 1999. PMID: 10228154 Free PMC article.
-
Nephrogenic diabetes insipidus.Semin Nephrol. 1999 Jul;19(4):344-52. Semin Nephrol. 1999. PMID: 10435672 Review.
-
An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex.J Clin Invest. 1998 Jul 1;102(1):57-66. doi: 10.1172/JCI2605. J Clin Invest. 1998. PMID: 9649557 Free PMC article.
-
V2R mutations and nephrogenic diabetes insipidus.Prog Mol Biol Transl Sci. 2009;89:15-29. doi: 10.1016/S1877-1173(09)89002-9. Epub 2009 Oct 7. Prog Mol Biol Transl Sci. 2009. PMID: 20374732 Review.
Cited by
-
Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.Endocr Rev. 2013 Apr;34(2):278-301. doi: 10.1210/er.2012-1044. Epub 2013 Jan 29. Endocr Rev. 2013. PMID: 23360744 Free PMC article. Review.
-
Congenital nephrogenic diabetes insipidus: the current state of affairs.Pediatr Nephrol. 2012 Dec;27(12):2183-204. doi: 10.1007/s00467-012-2118-8. Epub 2012 Mar 17. Pediatr Nephrol. 2012. PMID: 22427315 Review.
-
Congenital nephrogenic diabetes insipidus presented with bilateral hydronephrosis: genetic analysis of V2R gene mutations.Yonsei Med J. 2006 Feb 28;47(1):126-30. doi: 10.3349/ymj.2006.47.1.126. Yonsei Med J. 2006. PMID: 16502494 Free PMC article.
-
A case of aquaporin 2 R85X mutation in a boy with congenital nephrogenic diabetes insipidus.Pediatr Nephrol. 2008 Apr;23(4):663-5. doi: 10.1007/s00467-007-0682-0. Epub 2007 Nov 27. Pediatr Nephrol. 2008. PMID: 18040725
-
Treatment of congenital nephrogenic diabetes insipidus by hydrochlorothiazide and cyclooxygenase-2 inhibitor.Pediatr Nephrol. 2003 Oct;18(10):1073-6. doi: 10.1007/s00467-003-1195-0. Epub 2003 Jul 18. Pediatr Nephrol. 2003. PMID: 12883974
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases